NP Life Science Technologies Overview
- Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$16K
- Investors
-
2
NP Life Science Technologies General Information
Description
Developer of biodegradable cell growth scaffolds designed for research and development of functionalized polymer structures. The company specializes in producing implantable scaffolds made of polyphosphazene that support the body in the regeneration of peripheral nerves, helping clinicians to restore human organisms by regenerating traumatized tissues and restoring their functionality.
Contact Information
Website
www.nplifescience.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
- Hafenstraße 47-51
- Linz, 4020
- Austria
+43 0699 00000000
NP Life Science Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 13-Mar-2018 | $16K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Jan-2015 | Completed | Generating Revenue |
NP Life Science Technologies Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Claudia Schröder Ph.D | Founder & Chief Executive Officer | ||
| Oliver Brüggemann Ph.D | Chief Technology Officer | ||
| Ian Teasdale Ph.D | CSO |
NP Life Science Technologies Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Science4Life | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| tech2b | Accelerator/Incubator | 000 0000 | 000000 0 |